Further delineation of BCAP31-linked intellectual disability: description of 17 new families with LoF and missense variants

[1]  T. de Ravel,et al.  BCAP31-related syndrome: The first de novo report. , 2020, European journal of medical genetics.

[2]  K. Yoshiura,et al.  Possible mitochondrial dysfunction in a patient with deafness, dystonia, and cerebral hypomyelination (DDCH) due to BCAP31 Mutation , 2020, Molecular genetics & genomic medicine.

[3]  Sha-sha Jiang,et al.  Induction of Liver Steatosis in BAP31-Deficient Mice Burdened with Tunicamycin-Induced Endoplasmic Reticulum Stress , 2018, International journal of molecular sciences.

[4]  Alex Chapin,et al.  Expert Specification of the ACMG/AMP Variant Interpretation Guidelines for Genetic Hearing Loss , 2018, bioRxiv.

[5]  B. Wang,et al.  Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice[S] , 2017, Journal of Lipid Research.

[6]  H. Najmabadi,et al.  Copy Number Variants in Patients with Autism and Additional Clinical Features: Report of VIPR2 Duplication and a Novel Microduplication Syndrome , 2016, Molecular Neurobiology.

[7]  Keith Nykamp,et al.  Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria , 2017, Genetics in Medicine.

[8]  N. Monfared,et al.  BCAP31‐associated encephalopathy and complex movement disorder mimicking mitochondrial encephalopathy , 2017, American journal of medical genetics. Part A.

[9]  R. Mao,et al.  BCAP31 Mutation Causing a Syndrome of Congenital Dystonia, Facial Dysorphism and Central Hypomyelination Discovered Using Exome Sequencing , 2016, Movement disorders clinical practice.

[10]  C. Rosenberg,et al.  Genomic copy number alterations in non‐syndromic hearing loss , 2015, Clinical genetics.

[11]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[12]  H. Osaka,et al.  Genotype–phenotype correlation of contiguous gene deletions of SLC6A8, BCAP31 and ABCD1 , 2015, Clinical Genetics.

[13]  G. Raymond,et al.  Distal Xq28 microdeletions: Clarification of the spectrum of contiguous gene deletions involving ABCD1, BCAP31, and SLC6A8 with a new case and review of the literature , 2014, American journal of medical genetics. Part A.

[14]  Heidi L Rehm,et al.  American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss , 2014, Genetics in Medicine.

[15]  M. Lathrop,et al.  Mutations in BCAP31 cause a severe X-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the Golgi apparatus. , 2013, American journal of human genetics.

[16]  M. Mizuguchi,et al.  Contiguous ABCD1 DXS1357E deletion syndrome: Report of an autopsy case , 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.

[17]  A. Munnich,et al.  Phenotype and genotype in 101 males with X-linked creatine transporter deficiency , 2013, Journal of Medical Genetics.

[18]  N. Matsumoto,et al.  Contiguous deletion of SLC6A8 and BAP31 in a patient with severe dystonia and sensorineural deafness. , 2012, Molecular genetics and metabolism.

[19]  A. Helenius,et al.  BAP31 and BiP are essential for dislocation of SV40 from the endoplasmic reticulum to the cytosol , 2011, Nature Cell Biology.

[20]  S. High,et al.  Differences in endoplasmic-reticulum quality control determine the cellular response to disease-associated mutants of proteolipid protein , 2009, Journal of Cell Science.

[21]  David J Stephens,et al.  Bap31 is an itinerant protein that moves between the peripheral endoplasmic reticulum (ER) and a juxtanuclear compartment related to ER-associated Degradation. , 2008, Molecular biology of the cell.

[22]  A. Fulton,et al.  X-linked creatine transporter defect: A report on two unrelated boys with a severe clinical phenotype , 2006, Journal of Inherited Metabolic Disease.

[23]  G. Shore,et al.  Bap29/31 Influences the Intracellular Traffic of MHC Class I Molecules1 , 2004, The Journal of Immunology.

[24]  H. Moser,et al.  Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders. , 2002, American journal of human genetics.

[25]  V. Lennon,et al.  Endoplasmic Reticulum Membrane-sorting Protein of Lymphocytes (BAP31) Is Highly Expressed in Neurons and Discrete Endocrine Cells , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  Jyoti S. Choudhary,et al.  Proteomics Characterization of Abundant Golgi Membrane Proteins* , 2001, The Journal of Biological Chemistry.

[27]  W. Annaert,et al.  Export of Cellubrevin from the Endoplasmic Reticulum Is Controlled by BAP31 , 1997, The Journal of cell biology.

[28]  B. Poll-The,et al.  X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management , 2012 .